SAGIV, a semi-automatic, hand-held device for rapid, less painful, and safer intravenous (IV) insertion, is one of the first creations of Israel’s first Biodesign Medical Innovation Program, a joint project of the directors of the Hadassah Medical Center’s Heart Institute and the Hebrew University’s Center for Bioengineering.
The Biodesign program is aimed at enhancing the likelihood of medical innovations reaching the marketplace. Elements of SAGIV, which uses infrared technology and an LCD monitor to identify proper veins, has already been tested on difficult IV insertion cases at the Hadassah Medical Center. Its creators believe SAGIV “will revolutionize the standard of care for IV insertions.”
Watch the video about SAGIV.